Medidata’s patient portal — myMedidata — is a single-destination intuitive platform enabling patients to enroll and participate in clinical trial activities on a Rave Study. This platform is the industry’s single most comprehensive tool set for all aspects of site and remote based clinical research. myMedidata encompasses all of the capabilities of Medidata’s patient-facing solutions such as the COVID-19 Symptom Tracker, eConsent, eCOA, wearable and other biosensors, and enablement of hybrid and virtual trials. Patients will also be able to use myMedidata to identify other trials and registries that can support them in disease treatment options. myMedidata now presents the results from these patient-centric applications on one dashboard for ease of viewing creating a single platform experience for all patients.